Full text

Turn on search term navigation

The Journal retracts the article “Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route” [1].

Following the publication, concerns were brought to the attention of the Editorial Office regarding the overlapping figures between publications [1,2], representing different experimental conditions. More specifically, subfigures B and D of Figure 6 in publication [2] are duplicated as subfigures D and C of Figure 6 in publication [1], respectively.

The authors cooperated with the investigation and commented that the mistake occurred while finalizing the figures for both studies, and the wrong image was selected for publication [1]. The authors also provided raw data and other documents related to the histopathological experiments in the reported study. However, the Editorial Board and Editor in Chief determined that the evidence and explanation provided were insufficient to justify the overlap observed, and inconsistencies in the raw data provided meant that serious doubts remained regarding the reliability of the data provided. As a result, the Editorial Board and Editor in Chief were unable to confirm the reliability of the findings and subsequently decided to retract this paper.

This retraction was approved by the Editor in Chief of the journal Nanomaterials.

The authors did not agree to this retraction.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

1. Ahmed, O.A.A.; Fahmy, U.A.; Badr-Eldin, S.M.; Aldawsari, H.M.; Awan, Z.A.; Asfour, H.Z.; Kammoun, A.K.; Caruso, G.; Caraci, F.; Alfarsi, A. et al. RETRACTED: Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route. Nanomaterials; 2020; 10, 1270. [DOI: https://dx.doi.org/10.3390/nano10071270] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32610539]

2. Fahmy, U.A.; Ahmed, O.A.A.; Badr-Eldin, S.M.; Aldawsari, H.M.; Okbazghi, S.Z.; Awan, Z.A.; Bakhrebah, M.A.; Alomary, M.N.; Abdulaal, W.H.; Medina, C. et al. RETRACTED ARTICLE: Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin. Int. J. Nanomed.; 2020; 15, pp. 5253-5264. [DOI: https://dx.doi.org/10.2147/IJN.S258791] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32801690]

Word count: 353

Show less

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Details

Title
RETRACTED: Ahmed et al. Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route. Nanomaterials 2020, 10, 1270
Author
Ahmed, Osama A A 1   VIAFID ORCID Logo  ; Fahmy, Usama A 2   VIAFID ORCID Logo  ; Badr-Eldin, Shaimaa M 3 ; Aldawsari, Hibah M 2   VIAFID ORCID Logo  ; Awan, Zuhier A 4 ; Asfour, Hani Z 5 ; Kammoun, Ahmed K 6   VIAFID ORCID Logo  ; Caruso, Giuseppe 7   VIAFID ORCID Logo  ; Caraci, Filippo 8 ; Alfarsi, Anas 2 ; Al-Ghamdi, Raniyah A 9 ; Al-Ghamdi, Rawan A 10 ; Alhakamy, Nabil A 11   VIAFID ORCID Logo 

1  Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; [email protected] (O.A.A.A.); [email protected] (S.M.B.-E.); [email protected] (H.M.A.); [email protected] (A.A.); [email protected] (N.A.A.); Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia 
2  Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; [email protected] (O.A.A.A.); [email protected] (S.M.B.-E.); [email protected] (H.M.A.); [email protected] (A.A.); [email protected] (N.A.A.) 
3  Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; [email protected] (O.A.A.A.); [email protected] (S.M.B.-E.); [email protected] (H.M.A.); [email protected] (A.A.); [email protected] (N.A.A.); Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt 
4  Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia; [email protected] 
5  Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia; [email protected] 
6  Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; [email protected] 
7  Oasi Research Institute-IRCCS, Via Conte Ruggero, 73, 94018 Troina (EN), Italy; [email protected] (G.C.); [email protected] (F.C.) 
8  Oasi Research Institute-IRCCS, Via Conte Ruggero, 73, 94018 Troina (EN), Italy; [email protected] (G.C.); [email protected] (F.C.); Department of Drug Sciences, University of Catania, 95125 Catania, Italy 
9  Ibn Sina National College for Medical Studies, Clinical Pharmacy Department, Jeddah 22421, Saudi Arabia; [email protected] 
10  Ibn Sina National College for Medical Studies, Jeddah 22421, Saudi Arabia; [email protected] 
11  Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; [email protected] (O.A.A.A.); [email protected] (S.M.B.-E.); [email protected] (H.M.A.); [email protected] (A.A.); [email protected] (N.A.A.); Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah 21589, Saudi Arabia 
First page
174
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
20794991
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.3390/nano14020174
ProQuest document ID
2918782391
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.